Here are updates on two of your buys

Article Excerpt

Long-time readers know that we keep you informed of important news about the stocks we cover. That means highlighting developments and plans that promise to brighten prospects for investors. Here are two buys that stand out this month: BOSTON SCIENTIFIC CORP., $42.43, is a buy. The company (New York symbol BSX; TSINetwork Rating: Average) (bostonscientific.com; Shares o/s: 1.4 billion; Market cap: $60.3 billion; No divds.) develops and markets medical devices used in minimally invasive procedures. In the quarter ended June 30, 2022, Boston Scientific’s revenues rose 5.4%, to $3.24 billion from $3.08 billion a year earlier. Excluding one-time items, the company earned $635.0 million, or $0.44 a share, in the quarter. That’s up 10.1% from $577.0 million, or $0.40. The increase was partly the result of stronger sales of high-profit-margin products. Lower costs also contributed. Boston Scientific’s outlook is positive. In the past few months, it has gained regulatory approvals for several new products across all business categories. Ongoing clinical trials and an active development pipeline should…